Gore; Anuradha V.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Gore; Anuradha V..The latest application filed is for "non-irritating testosterone emulsions".
Company Profile
10.23.46
- Gore; Anuradha V. - Irvine CA
- Gore; Anuradha V. - Aliso Viejo CA
- Gore; Anuradha V. - Aliso Viego CA
Patent Activity
| Patent | Date |
|---|---|
| Non-irritating Testosterone Emulsions App 20220202829 - Trogden; John T. ; et al. | 2022-06-30 |
| Stabilized Omega-3 Ophthalmic Compositions App 20220143122 - Gore; Anuradha V. ; et al. | 2022-05-12 |
| Artificial Tears And Therapeutic Uses App 20220008496 - Gore; Anuradha V. ; et al. | 2022-01-13 |
| Macrogol 15 Hydroxystearate Formulations App 20210275497 - Gore; Anuradha V. ; et al. | 2021-09-09 |
| Androgen Composition For Treating An Opthalmic Condition App 20210268002 - Trogden; John T. ; et al. | 2021-09-02 |
| Crystalline Form Of Cyclosporin A, Methods Of Preparation, And Methods For Use Thereof App 20210269484 - Gore; Anuradha V. ; et al. | 2021-09-02 |
| Artificial tears and therapeutic uses Grant 11,045,515 - Gore , et al. June 29, 2 | 2021-06-29 |
| Non-irritating Testosterone Emulsions App 20210113588 - Trogden; John` T. ; et al. | 2021-04-22 |
| Androgen composition for treating an ophthalmic condition Grant 10,905,696 - Trogden , et al. February 2, 2 | 2021-02-02 |
| Non-irritating testosterone emulsions Grant 10,780,098 - Trogden , et al. Sept | 2020-09-22 |
| Suspension compositions of cyclosporin A for subconjunctival and periocular injection Grant 10,780,048 - Gore , et al. Sept | 2020-09-22 |
| Suspensions Of Cyclosporin A Form 2 App 20190343917 - Gore; Anuradha V. ; et al. | 2019-11-14 |
| Stabilized Omega-3 Ophthalmic Compositions App 20190298790 - Gore; Anuradha V. ; et al. | 2019-10-03 |
| Two Part Formulation System For Ophthalmic Delivery App 20190290722 - Gore; Anuradha V. ; et al. | 2019-09-26 |
| Two part formulation system for ophthalmic delivery Grant 10,314,887 - Gore , et al. | 2019-06-11 |
| Stabilized omega-3 ophthalmic compositions Grant 10,279,005 - Gore , et al. | 2019-05-07 |
| Suspensions of cyclosporin A form 2 Grant 10,206,971 - Gore , et al. Feb | 2019-02-19 |
| Artificial Tears And Therapeutic Uses App 20180264063 - Gore; Anuradha V. ; et al. | 2018-09-20 |
| Non-irritating Testosterone Emulsions App 20180221388 - Trogden; John T. ; et al. | 2018-08-09 |
| Non-irritating testosterone emulsions Grant 9,937,188 - Trogden , et al. April 10, 2 | 2018-04-10 |
| Fixed Dose Combination Of Brimonidine And Timolol App 20180078500 - Jiao; Jim ; et al. | 2018-03-22 |
| Artificial tears and therapeutic uses Grant 9,821,020 - Gore , et al. November 21, 2 | 2017-11-21 |
| Two Part Formulation System For Ophthalmic Delivery App 20170209532 - Gore; Anuradha V. ; et al. | 2017-07-27 |
| Androgen Composition For Treating An Opthalmic Condition App 20170189412 - Trogden; John T. ; et al. | 2017-07-06 |
| Two part formulation system for ophthalmic delivery Grant 9,616,017 - Gore , et al. April 11, 2 | 2017-04-11 |
| Ophthalmic compositions comprising polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers Grant 9,579,385 - Gore , et al. February 28, 2 | 2017-02-28 |
| Androgen composition for treating an opthalmic condition Grant 9,504,646 - Trogden , et al. November 29, 2 | 2016-11-29 |
| Two Part Formulation System For Ophthalmic Delivery App 20160235666 - Gore; Anuradha V. ; et al. | 2016-08-18 |
| Stabilized Omega-3 Ophthalmic Compositions App 20160143977 - Gore; Anuradha V. ; et al. | 2016-05-26 |
| Suspensions Of Cyclosporin A Form 2 App 20160129074 - Gore; Anuradha V. ; et al. | 2016-05-12 |
| Crystalline Form Of Cyclosporin A, Methods Of Preparation, And Methods For Use Thereof App 20160083432 - Gore; Anuradha V. ; et al. | 2016-03-24 |
| Suspension Compositions Of Cyclosporin A For Subconjunctival And Periocular Injection App 20160015632 - Gore; Anuradha V. ; et al. | 2016-01-21 |
| Suspensions of cyclosporin A form 2 Grant 9,238,002 - Gore , et al. January 19, 2 | 2016-01-19 |
| Androgen Composition For Treating An Opthalmic Condition App 20150366800 - Trogden; John T. ; et al. | 2015-12-24 |
| Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof Grant 9,206,228 - Gore , et al. December 8, 2 | 2015-12-08 |
| Androgen composition for treating an opthalmic condition Grant 9,119,772 - Trogden , et al. September 1, 2 | 2015-09-01 |
| Cyclosporin Emulsions App 20150045309 - Morgan; Aileen ; et al. | 2015-02-12 |
| Ophthalmic formulations containing substituted gamma lactams and methods for use thereof Grant 8,952,051 - Gore , et al. February 10, 2 | 2015-02-10 |
| Two Part Formulation System For Ophthalmic Delivery App 20140364379 - Gore; Anuradha V. ; et al. | 2014-12-11 |
| Suspensions Of Cyclosporin A Form 2 App 20140322335 - Gore; Anuradha V. ; et al. | 2014-10-30 |
| Non-irritating Testosterone Emulsions App 20140315872 - Trogden; John T. ; et al. | 2014-10-23 |
| Crystalline Form Of Cyclosporine A, Methods Of Preparation, And Methods For Use Thereof App 20140315827 - Gore; Anuradha V. ; et al. | 2014-10-23 |
| Macrogol 15 Hydroxystearate Formulations App 20140287988 - GORE; ANURADHA V. ; et al. | 2014-09-25 |
| Fixed Dose Combination Of Bimatoprost And Brimonidine App 20140249153 - Graham; Richard S. ; et al. | 2014-09-04 |
| Crystalline form of cyclosporine A, methods of preparation, and methods for use thereof Grant 8,772,245 - Gore , et al. July 8, 2 | 2014-07-08 |
| Artificial Tears And Therapeutic Uses App 20140141106 - GORE; ANURADHA V. ; et al. | 2014-05-22 |
| Ophthalmic Compositions Comprising Polyvinyl Caprolactam-polyvinyl Acetate-polyethylene Glycol Graft Copolymers App 20140128329 - Gore; Anuradha V. ; et al. | 2014-05-08 |
| Artificial tears and therapeutic uses Grant 8,679,554 - Gore , et al. March 25, 2 | 2014-03-25 |
| Artificial Tears And Therapeutic Uses App 20130295206 - GORE; ANURADHA V. ; et al. | 2013-11-07 |
| Artificial tears and therapeutic uses Grant 8,496,976 - Gore , et al. July 30, 2 | 2013-07-30 |
| Ophthalmic Compositions Comprising Polyvinyl Capralactam-polyvinyl Acetate-polyethylene Glycol Graft Copolymers App 20130157963 - Gore; Anuradha V. ; et al. | 2013-06-20 |
| Two Part Formulation System For Opthalmic Delivery App 20130029919 - GORE; Anuradha V. ; et al. | 2013-01-31 |
| Fixed Dose Combination Of Bimatoprost And Brimonidine App 20130023536 - Graham; Richard S. ; et al. | 2013-01-24 |
| Crystalline Form Of Cyclosporine A, Methods Of Preparation, And Methods For Use Thereof App 20130023482 - Gore; Anuradha V. ; et al. | 2013-01-24 |
| Compositions For Enhancing Hair Growth App 20130011354 - Gore; Anuradha V. ; et al. | 2013-01-10 |
| Macrogol 15 Hydroxystearate Formulations App 20130005665 - Gore; Anuradha V. ; et al. | 2013-01-03 |
| Artificial Tears and Therapeutic Uses App 20120201910 - Gore; Anuradha V. ; et al. | 2012-08-09 |
| Androgen Composition For Treating An Opthalmic Condition App 20120190661 - Trogden; John T. ; et al. | 2012-07-26 |
| Compositions For Enhancing Hair Growth App 20110112198 - Gore; Anuradha V. ; et al. | 2011-05-12 |
| Ophthalmic Formulations Containing Substituted Gamma Lactams And Methods For Use Thereof App 20110105581 - Gore; Anuradha V. ; et al. | 2011-05-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 